16 septiembre 2015
Accurately determining HER2 status in patients with breast cancer is a critical prognostic and predictive factor and identifies patients who may benefit from treatment with anti-HER2 therapies.
http://www.sciencedaily.com/releases/2015/09/150916133659.htm
